Low Cylinder Toric

Alcon

Status and phase: Completed; Phase 4

Conditions: Cataracts

Treatments: Device: Toric IOL (SN60T3)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00732030

M07-005

Details and patient eligibility

About

Study evaluates the visual outcomes and patient satisfaction after implantation of a toric intraocular lens (IOL).

Enrollment: 26 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with Cataracts
• Predicted residual corneal astigmatism between 0.75 and 1.03 Diopters (D)

Exclusion criteria

• Preoperative ocular pathology
• Planned monovision

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

26 participants in 1 patient group

AcrySof Toric T3

Experimental group

Description:

Each enrolled eye receives AcrySof Toric Model SN60T3 Intraocular Lens (IOL)

Treatment:

Device: Toric IOL (SN60T3)